Skip to main content

Abdolreza Haririan, MD, MPH

Academic Title:

Professor

Primary Appointment:

Medicine

Location:

29 South Greene Street, 217-A

Phone (Primary):

(410) 328-2010

Phone (Secondary):

(410) 328-5720

Fax:

(410) 328-5685

Education and Training

  • Tehran University of Medical Sciences, MD
  • Johns Hopkins Bloomberg School of Public Health, MPH
  • Detroit Medical Center/Wayne State University, Internship and Residency
  • Johns Hopkins Hospital, Nephrology Training
  • University of Maryland Medical Center, Fellowship, Transplant Nephrology

Biosketch

Dr. Haririan is a Professor of Medicine in the Division of Nephrology.  He served as the medical director of the kidney and pancreas transplant program in Harper University Hospital in Detroit from 2001 to 2005, and then joined to transplant program at the University of Maryland Medical Center.

He is currently the Medical Director of the kidney and pancreas transplant programs and the Director of Transplant Nephrology Fellowship Training Program. He is serving on the editorial board of Clinical Nephrology and Transplantation journals and reviews manuscripts for close to 20 major journals, including the Journal of the American Society of Nephrology, the American Journal of Kidney Disease, the American Journal of Transplantation, and Transplantation.

Dr. Haririan is a member of numerous professional associations, including the American Society of Nephrology, the International Society of Nephrology, the American transplant Society and the Transplantation Society. His clinical interests include kidney and pancreas transplantation.

Research/Clinical Keywords

antibody-mediated graft injury in kidney transplantation, BK nephropathy, non-traditional risk factors for poor transplant outcomes, pancreas allograft rejection and optimization of immunosuppression, renal and transplant medicine, antibody-mediated rejection, Acthar, glomerulopathy.

Highlighted Publications

Haririan A. Current status of the evaluation and management of antibody-mediated rejection in kidney transplantation. Curr Opin Nephrol Hypertens. 2015 Nov;24(6):576-81

Salzberg DJ, Karadsheh FF, Haririan A, Reddivari V, Weir MR. Specific management of anemia and hypertension in renal transplant recipients: influence of renin-angiotensin system blockade. Am J Nephrol. 2014;39(1):1-7.

Papadimitriou JC, Drachenberg CB, Ramos E, Kukuruga D, Klassen DK, Ugarte R, Nogueira J, Cangro C, Weir MR, Haririan A. Antibody-mediated allograft rejection: morphologic spectrum and serologic correlations in surveillance and for cause biopsies. Transplantation. 2013 Jan 15;95(1):128-36.

Jones H, Talwar M, Nogueira JM, Ugarte R, Cangro C, Rasheed H, Klassen DK, Weir MR, Haririan A. Anemia after kidney transplantation; its prevalence, risk factors, and independent association with graft and patient survival: a time-varying analysis. Transplantation. 2012 May 15;93(9):923-8.

Drachenberg CB, Torrealba JR, Nankivell BJ, Rangel EB, Bajema IM, Kim DU, Arend L, Bracamonte ER, Bromberg JS, Bruijn JA, Cantarovich D, Chapman JR, Farris AB, Gaber L, Goldberg JC, Haririan A, Honsová E, Iskandar SS, Klassen DK, Kraus E, Lower F, Odorico J, Olson JL, Mittalhenkle A, Munivenkatappa R, Paraskevas S, Papadimitriou JC, Randhawa P, Reinholt FP, Renaudin K, Revelo P, Ruiz P, Samaniego MD, Shapiro R, Stratta RJ, Sutherland DE, Troxell ML, Voska L, Seshan SV, Racusen LC, Bartlett ST. Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts-updated Banff grading schema. Am J Transplant. 2011 Sep;11(9):1792-802

Additional Publication Citations

Research Interests

Clinical Specialty Details

×